Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats

Hypertension Research

Volumn 35, Issue 4, 2012, Pages 470-476

  Nakagaki, Toshiaki ^a   Hirooka, Yoshitaka ^a   Matsukawa, Ryuichi ^a   Nishihara, Masaaki ^a   Nakano, Masatsugu ^a   Ito, Koji ^a   Hoka, Sumio ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

blood pressure; mineralocorticoid receptor; rostral ventrolateral medulla; sympathetic nervous system

Indexed keywords

ALDOSTERONE; EPLERENONE; MINERALOCORTICOID RECEPTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HYPERTENSION; MALE; MICROINJECTION; NERVE CONDUCTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; ROSTRAL VENTROLATERAL MEDULLA; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; BLOOD PRESSURE; HYPERTENSION; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; STROKE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84859599642     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.220     Document Type: Article

References (49)

1. Esler M. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 2010; 108: 227-237.
2. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54: 690-697.
3. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7: 335-346.
4. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321. (Pubitemid 36384098)
5. Yagi S, Akaike M, Aihara K, Iwase T, Yoshida S, Sumitomo-Ueda Y, Ikeda Y, Ishikawa K, Matsumoto T, Sata M. High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension. Hypertens Res 2011; 34: 74-78.
6. Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL. Eplerenone prevents saltinduced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2004; 43: 1252-1257. (Pubitemid 38691747)
7. Kimura S, Ito M, Tomita M, Hoyano M, Obata H, Ding L, Chinushi M, Hanawa H, Kodama M, Aizawa Y. Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats. Hypertens Res 2011; 34: 584-591.
8. Min LJ, Mogi M, Iwanami J, Sakata A, Jing F, Tsukuda K, Ohshima K, Horiuchi M. Angiotensin II and aldosterone-induced neuronal damage in neurons through an astrocyte-dependent mechanism. Hypertens Res 2011; 34: 773-778.
9. Nakamura T, Fukuda M, Kataoka K, Nako H, Tokutomi Y, Dong YF, Yamamoto E, Yasuda O, Ogawa H, Kim-Mitsuyama S. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats. Hypertens Res 2011; 34: 817-824.
10. Takeda Y. Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension. Hypertens Res 2009; 32: 321-324.
11. Schild L. The epithelial sodium channel and the control of sodium balance. Biochim Biophys Acta 2010; 1802: 1159-1165.
12. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol 2009; 297: F559-F576.
13. Amin MS, Wang HW, Reza E, Whitman SC, Tuana BS, Leenen FH. Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1787-R1797. (Pubitemid 41643225)
14. Gomez-Sanchez EP, Gomez-Sanchez CM, Plonczynski M, Gomez-Sanchez CE. Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension. Exp Physiol 2010; 95: 120-130.
15. Kumar NN, Goodchild AK, Li Q, Pilowsky PM. An aldosterone-related system in the ventrolateral medulla oblongata of spontaneously hypertensive and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol 2006; 33: 71-75.
16. Comer AM, Gibbons HM, Qi J, Kawai Y, Win J, Lipski J. Detection of mRNA species in bulbospinal neurons isolated from the rostral ventrolateral medulla using single-cell RTPCR. Brain Res Brain Res Protoc 1999; 4: 367-377.
17. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep 2003; 5: 262-268. (Pubitemid 38914970)
18. Hirooka Y. Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension. Hypertens Res 2011; 34: 407-412.
19. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-2362. (Pubitemid 38656873)
20. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation. - Pathogenesis of hypertension and therapeutic aspects -. Circ J 2010; 74: 827-835.
21. Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF. Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension 2002; 40: 552-559.
22. Kishi T, Hirooka Y, Konno S, Ogawa K, Sunagawa K. Angiotensin II type 1 receptoractivated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 2010; 55: 291-297.
23. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976; 7: 46-53.
24. Zhu DN, Xue LM, Li P. Cardiovascular effects of microinjection of corticoids and antagonists into the rostral ventrolateral medulla in rats. Blood Press 1995; 4: 55-62.
25. Matsukawa R, Hirooka Y, Nishihara M, Ito K, Sunagawa K. Neuregulin-1/ErbB signaling in rostral ventrolateral medulla is involved in blood pressure regulation as an antihypertensive system. J Hypertens 2011; 29: 1735-1742.
26. Koga Y, Hirooka Y, Araki S, Nozoe M, Kishi T, Sunagawa K. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens Res 2008; 31: 2075-2083.
27. Gabor A, Leenen FH. Mechanisms in the PVN mediating local and central sodiuminduced hypertension in Wistar rats. Am J Physiol Regul Integr Comp Physiol 2009; 296: R618-R630.
28. Huang BS, White RA, Jeng AY, Leenen FH. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl saltsensitive rats. Am J Physiol Regul Integr Comp Physiol 2009; 296: R994-R1000.
29. Huang BS, Leenen FH. Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol 2005; 288: H2491-H2497. (Pubitemid 40604139)
30. Ito K, Hirooka Y, Sunagawa K. Blockade of mineralocorticoid receptors improves saltinduced left-ventricular systolic dysfunction through attenuation of enhanced sympathetic drive in mice with pressure overload. J Hypertens 2010; 28: 1449-1458.
31. Wulff P, Vallon V, Huang DY, Volkl H, Yu F, Richter K, Jansen M, Schlunz M, Klingel K, Loffing J, Kauselmann G, Bosl MR, Lang F, Kuhl D. Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest 2002; 110: 1263-1268. (Pubitemid 35285752)
32. Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 2007; 49: 355-364. (Pubitemid 46143013)
33. Zhou ZH, Bubien JK. Nongenomic regulation of ENaC by aldosterone. Am J Physiol Cell Physiol 2001; 281: C1118-C1130.
34. Gros R, Ding Q, Armstrong S, O'Neil C, Pickering JG, Feldman RD. Rapid effects of aldosterone on clonal human vascular smooth muscle cells. Am J Physiol Cell Physiol 2007; 292: C788-C794.
35. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-364. (Pubitemid 24127645)
36. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 2008; 294: H1067-H1074. (Pubitemid 351253321)
37. Huang BS, Leenen FH. Mineralocorticoid actions in the brain and hypertension. Curr Hypertens Rep 2011; 13: 214-220.
38. Wang H, Huang BS, Leenen FH. Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 2003; 285: H2516-H2523. (Pubitemid 37443069)
39. Huang BS, Leenen FH. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain II ANG. Am J Physiol 1996; 270: H275-H280.
40. Teruya H, Yamazato M, Muratani H, Sakima A, Takishita S, Terano Y, Fukiyama K. Role of ouabain-like compound in the rostral ventrolateral medulla in rats. J Clin Invest 1997; 99: 2791-2798. (Pubitemid 27259827)
41. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 2005; 288: E342-E346. (Pubitemid 40110641)
42. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM, Felder RB. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension 2008; 51: 727-733. (Pubitemid 351301527)
43. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14: 1370-1376.
44. Huang BS, Wang H, Leenen FH. Enhanced sympathoexcitatory and pressor responses to central Na+ in Dahl salt-sensitive vs. -resistant rats. Am J Physiol Heart Circ Physiol 2001; 281: H1881-H1889.
45. Abrams JM, Osborn JW. A role for benzamil-sensitive proteins of the central nervous system in the pathogenesis of salt-dependent hypertension. Clin Exp Pharmacol Physiol 2008; 35: 687-694. (Pubitemid 351490104)
46. Huang BS, Cheung WJ, Wang H, Tan J, White RA, Leenen FH. Activation of brain reninangiotensin- aldosterone system by central sodium in Wistar rats. Am J Physiol Heart Circ Physiol 2006; 291: H1109-H1117. (Pubitemid 44343654)
47. Nishimura M, Ohtsuka K, Nanbu A, Takahashi H, Yoshimura M. Benzamil blockade of brain Na+ channels averts Na(+)-induced hypertension in rats. Am J Physiol 1998; 274: R635-R644.
48. de Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 2000; 57: 1329-1336. (Pubitemid 30207887)
49. Geerling JC, Kawata M, Loewy AD. Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol 2006; 494: 515-527. (Pubitemid 41790999)